We use cookies to ensure the website works properly and to improve your experience. By continuing to use the website, you agree to their use.
Для размещения заказа оставьте ваш номер телефона. Мы с вами свяжемся в ближайшее время
Рассчитать стоимость заказа
Оставьте свои контакты и мы свяжемся с вами в ближайшее время
RAPID RSV Ag
Registration Certificate: No. RZN 2024/23198
A lateral flow immunoassay for qualitative detection of Respiratory Syncytial Virus (RSV) antigen in nasopharyngeal swab specimens
The Current Diagnostic Landscape
Global Health Impact
According to the WHO, Respiratory Syncytial Virus (RSV) is a top-3 viral threat for infants, causing over 3.5 million hospitalizations and 100,000 deaths annually.
The Diagnostic Challenge
RSV symptoms often mimic a common cold, leading to delayed diagnosis. Without early detection, the infection can rapidly progress to bronchiolitis, pneumonia, and respiratory failure, requiring intensive clinical intervention.
Rapid Bio Solution
With increasing global focus on RSV, the Rapid Bio RSV Test provides the essential speed and accuracy for early-stage diagnosis at the point of care, preventing severe complications and improving patient outcomes.
According to the WHO, Respiratory Syncytial Virus (RSV) is a top-3 viral threat for infants, causing over 3.5 million hospitalizations and 100,000 deaths annually.
The Diagnostic Challenge
RSV symptoms often mimic a common cold, leading to delayed diagnosis. Without early detection, the infection can rapidly progress to bronchiolitis, pneumonia, and respiratory failure, requiring intensive clinical intervention.
Rapid Bio Solution
With increasing global focus on RSV, the Rapid Bio RSV Test provides the essential speed and accuracy for early-stage diagnosis at the point of care, preventing severe complications and improving patient outcomes.
Clinical Impact & Benefits
01
Early Pediatric Detection
As a leading cause of bronchiolitis and pneumonia, early RSV detection is critical. Rapid testing distinguishes standard ARVIs from high-risk infections, ensuring timely hospitalization and the prevention of respiratory failure.
02
Protection of High-Risk Groups
RSV poses a severe threat to infants (preterm), elderly, and immunocompromised patients. Immediate diagnostic results allow for rapid clinical intervention in these vulnerable populations, significantly improving prognosis.
Key Advantages
Accurate differentiation between viral and bacterial pathogens.
Prevention of unjustified and excessive antibiotic use.
Early intervention to avoid severe respiratory complications.
Technical Specifications
Time to Result:
5 minutes
Result Stability:
20 minutes
Reproducibility:
100%
Sensitivity (LoD):
40 ng/mL
Interpretation
NEGATIVE RESULT
Appearance in the test window of only the control line “C”. Staining of the test line “T” does not occur.
Positive result
Appearance in the test window of two colored lines: the control line “C” and the test line “T”.
The color intensity of the test line may vary.
The color intensity of the test line may vary.
Invalid result
In the test window, the control line “C” does not appear regardless of the presence of the test line “T”.
The cause of an invalid result may be incorrect performance of the analysis procedure or unsuitability of the medical device. In this case, it is recommended to repeat the testing procedure.
The cause of an invalid result may be incorrect performance of the analysis procedure or unsuitability of the medical device. In this case, it is recommended to repeat the testing procedure.
Submit a request to receive a commercial offer
We will contact you shortly
Related Products
